Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

Share Price is delayed by 15 minutes
Get Live Data
11.00    0.00 (0.00%)
Bid:
10.50
Ask:
11.50
Spread: 1.00 (9.524%)
Market Cap: £24.00m
SOS Live PriceLast checked at - London Stock Exchange

Intraday Sosandar Share Chart

Director/PDMR Shareholding

10 Apr 2017 14:20

RNS Number : 0939C
Orogen PLC
10 April 2017
 

 

 

 

Orogen plc

("Orogen" or the "Company")

 

Transaction Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a.

Name

Adam Reynolds

 

2

Reason for notification

 

 

a.

Position/Status

Director/Chairman

 

b.

Initial notification/

Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a.

Name

Orogen plc

 

b.

LEI

213800GBJ1RNNUKP2182

 

4 (i)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 0.01p each

 

 

ISIN: GB00BYXD4566

 

b.

Nature of the transaction

Subscription - Placing

 

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Date

 

1.5p

5,666,667

10.04.17

 

 

 

 

d.

Aggregated information

- Aggregated Volume

- Price

 

5,666,667

1.5p

 

e.

Date of the transaction

10 April 2017

 

f.

Place of the transaction

London Stock Exchange (XLON)

 

4 (ii)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 0.01p each

 

ISIN: GB00BYXD4566

 

b.

Nature of the transaction

Subscription - Open Offer

 

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Date

 

1.5p

348,162

10.04.17

 

 

 

 

d.

Aggregated information

- Aggregated Volume

- Price

 

 

 

348,162

1.5p

 

e.

Date of the transaction

10 April 2017

 

f.

Place of the transaction

London Stock Exchange (XLON)

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a.

Name

Steven Metcalfe

 

2

Reason for notification

 

 

 

 

a.

Position/Status

Director

 

b.

Initial notification/

Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a.

Name

Orogen plc

 

b.

LEI

213800GBJ1RNNUKP2182

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 0.01p each

 

ISIN: GB00BYXD4566

 

b.

Nature of the transaction

Subscription - Placing

 

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Date

 

1.5p

5,666,667

10.04.17

 

 

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

 

 

5,666,667

 

1.5p

 

 

e.

Date of the transaction

10 April 2017

 

f.

Place of the transaction

London Stock Exchange (XLON)

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a.

Name

Mark Collingbourne

 

2

Reason for notification

 

 

 

 

a.

Position/Status

Director

 

b.

Initial notification/

Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a.

Name

Orogen plc

 

b.

LEI

213800GBJ1RNNUKP2182

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 0.01p each

 

ISIN: GB00BYXD4566

 

b.

Nature of the transaction

Subscription - Placing

 

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Date

 

1.5p

2,666,667

10.04.17

 

 

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

 

 

2,666,667

 

1.5p

 

 

e.

Date of the transaction

10 April 2017

 

f.

Place of the transaction

London Stock Exchange (XLON)

 

 

 

Enquiries:

 

Orogen plc

Adam Reynolds, Non-executive Chairman

 

C/o Walbrook

Cairn Financial Advisers LLP (Nominated Adviser)

Liam Murray / Sandy Jamieson

 

+44 (0) 20 7213 0880

Turner Pope Investments (TPI) Ltd (Broker)

Ben Turner / James Pope

 

+44 (0) 20 3621 4120

Walbrook (Public Relations and Investor Relations)

Paul Cornelius / Gary Middleton

 

+44 (0) 20 7933 8780

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBXGDSIBBBGRG
Date   Source Headline
18th Mar 20209:00 amRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSTrading and COVID-19 Update
4th Mar 20201:34 pmRNSHolding(s) in Company
2nd Mar 20202:55 pmRNSResult of GM & Director/PDMR transactions
12th Feb 20201:50 pmRNSResults of Placing to raise £5 million
12th Feb 202011:14 amRNSPlacing to raise £5 million
20th Jan 20207:00 amRNSTrading Update
27th Nov 20199:57 amRNSInterim Results: Replacement
27th Nov 20197:05 amRNSInterim Results
28th Oct 20197:00 amRNSHalf Year Trading Update
23rd Sep 20194:24 pmRNSResult of AGM
23rd Sep 20197:00 amRNSAGM Statement
29th Aug 20197:00 amRNSNotice of AGM and Posting of ARA
2nd Aug 20195:13 pmRNSHolding(s) in Company
31st Jul 20194:27 pmRNSHolding(s) in Company
31st Jul 201911:21 amRNSHolding(s) in Company
29th Jul 201911:18 amRNSResult of General Meeting
11th Jul 20194:35 pmRNSPrice Monitoring Extension
11th Jul 20197:00 amRNSPlacing to raise £7 million
3rd Jul 20197:00 amRNSFull Year Results
9th May 20197:00 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSTrading Update
27th Feb 20193:26 pmRNSGrant of options / PDMR dealing
24th Jan 20195:18 pmRNSDirector/PDMR Shareholding
9th Jan 20197:00 amRNSTrading Update
20th Dec 201812:44 pmRNSDirector/PDMR Shareholding
17th Dec 201811:05 amRNSSecond Price Monitoring Extn
17th Dec 201811:00 amRNSPrice Monitoring Extension
21st Nov 20187:00 amRNSInterim Results
15th Oct 20189:25 amRNSHolding(s) in Company
10th Oct 20187:05 amRNSPlacing to raise £3.0 million
10th Oct 20187:00 amRNSHalf Year Trading Update
19th Sep 20182:13 pmRNSResult of AGM
19th Sep 20187:00 amRNSAGM Statement
28th Aug 20184:35 pmRNSPrice Monitoring Extension
24th Aug 20187:00 amRNSNotice of AGM
13th Jul 20184:40 pmRNSSecond Price Monitoring Extn
13th Jul 20184:35 pmRNSPrice Monitoring Extension
11th Jul 20184:41 pmRNSSecond Price Monitoring Extn
11th Jul 20184:35 pmRNSPrice Monitoring Extension
11th Jul 20187:05 amRNSChange of Adviser
11th Jul 20187:00 amRNSFinal Results
29th Jun 20187:00 amRNSDirector Appointment
16th May 20187:00 amRNSTrading Update
17th Apr 20187:00 amRNSSosandar to present at the UK Investor Show
11th Apr 20183:41 pmRNSHolding(s) in Company
29th Mar 20187:00 amRNSInterim Results
12th Feb 20187:00 amRNSTrading Update
21st Dec 20177:00 amRNSChange of Accounting Year End
15th Dec 201711:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.